IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q3 2025 Holdings

Filed 2025-11-14 | 27 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vanguard Index FDS(VTI)TOTAL STK MKT922908769$340.8M1,038,55022.0%
Brookfield Corp(BN)CL A LTD VT SH11271J107$159.8M2,330,83010.3%
Asml Holding N V(ASML)N Y REGISTRY SHSN07059210$141.2M145,8369.1%
Mirum Pharmaceuticals Inc(MIRM)COM604749101$92.7M1,264,0286.0%
Edgewise Therapeutics Inc(EWTX)COM28036F105$86.8M5,350,0005.6%
Salesforce Inc(CRM)COM79466L302$78.3M330,1875.0%
Merus N VCOMN5749R100$70.6M750,0004.6%
Crinetics Pharmaceuticals in(CRNX)COM22663K107$67.7M1,625,0004.4%
Viridian Therapeutics Inc(VRDN)COM92790C104$51.4M2,380,0003.3%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$46.0M257,3273.0%
Zenas Biopharma Inc(ZBIO)COM98937L105$44.4M2,000,0002.9%
Pharvaris N V(PHVS)COMN69605108$43.7M1,750,0002.8%
Recursion Pharmaceuticals in(RXRX)CL A75629V104$38.7M7,929,8352.5%
Arrivent Biopharma Inc(AVBP)COM04272N102$35.8M1,942,1422.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$35.7M660,0002.3%
Vaxcyte Inc(PCVX)COM92243G108$33.0M916,1602.1%
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$31.0M1,200,0002.0%
Enliven Therapeutics Inc(ELVN)COM29337E102$29.2M1,426,2601.9%
Insmed Inc(INSM)COM PAR $.01457669307$28.8M200,0001.9%
Valneva SE(VALN)SPONSORED ADS92025Y103$28.6M2,345,0001.8%
Bridgebio Oncology Therapeut(BBOT)COM NEW107924102$22.7M1,961,3171.5%
Apogee Therapeutics Inc(APGE)COM03770N101$19.9M500,0001.3%
4D Molecular Therapeutics in(FDMT)COM35104E100$17.4M2,000,0001.1%
Lanzatech Global Inc(LNZA)COM NEW51655R200$3.9M158,1480.2%
Marqeta Inc(MQ)CLASS A COM57142B104$2.3M441,5580.2%
IO Biotech Inc(IOBT)COM449778109$912.3K2,512,4530.1%
Galecto Inc(GLTO)COM NEW36322Q206$322.1K86,5790.0%